Yulin Liao Selected Research

Charybdotoxin (ChTX)

12/2004	Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts.
9/2002	Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yulin Liao Research Topics

Disease

37	Neoplasms (Cancer) 01/2022 - 01/2008
25	Heart Failure 06/2022 - 10/2003
21	Myocardial Infarction 11/2022 - 02/2011
20	Hypertrophy 06/2022 - 09/2002
18	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2002
16	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2012
15	Body Weight (Weight, Body) 01/2020 - 09/2002
14	Fibrosis (Cirrhosis) 01/2022 - 05/2013
10	Hypoxia (Hypoxemia) 01/2021 - 11/2011
10	Infarction (Infarctions) 05/2018 - 09/2002
9	Inflammation (Inflammations) 01/2022 - 01/2011
9	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2014
8	Reperfusion Injury 01/2021 - 09/2002
8	Ischemia 10/2016 - 01/2002
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 09/2002
6	Abdominal Aortic Aneurysm 03/2022 - 01/2019
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2006
4	Aneurysm (Aneurysms) 03/2022 - 01/2019
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2013
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 03/2019
4	Cardio-Renal Syndrome 01/2022 - 01/2019
4	Atherosclerosis 01/2020 - 08/2011
3	Hyperglycemia 01/2022 - 04/2006
3	Infections 01/2022 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2010
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 11/2013
3	Thrombosis (Thrombus) 11/2019 - 01/2012
3	Glucose Intolerance 05/2013 - 04/2006
3	Coronary Occlusion 12/2004 - 09/2002
2	Diabetes Mellitus 01/2022 - 05/2013
2	Melanoma (Melanoma, Malignant) 01/2021 - 04/2019
2	Emergence Delirium 08/2020 - 01/2020
2	Hemorrhage 01/2020 - 01/2020
2	Aortic Aneurysm (Aneurysm, Aortic) 01/2019 - 01/2019
2	Thoracic Aorta Dissection 01/2018 - 10/2017
2	Necrosis 11/2015 - 10/2013

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
11	Long Noncoding RNAIBA 12/2021 - 01/2017
8	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2018
8	Angiotensin IIIBA 01/2022 - 10/2003
7	Circular RNAIBA 11/2022 - 10/2017
7	CateninsIBA 03/2022 - 10/2016
5	Messenger RNA (mRNA)IBA 01/2022 - 03/2010
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2002
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2015
5	Adenosine (Adenocard)FDA LinkGeneric 10/2011 - 01/2002
4	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
4	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 09/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 07/2006
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2011 - 01/2002
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2015
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 10/2011
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019 - 04/2015
3	UbiquitinIBA 01/2019 - 02/2006
3	Chemokine CX3CL1IBA 10/2016 - 12/2011
3	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2014
3	CalcineurinIBA 04/2015 - 01/2014
3	Phosphotransferases (Kinase)IBA 10/2013 - 09/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2004 - 09/2002
2	Cysteine (L-Cysteine)FDA Link 03/2022 - 01/2021
2	VimentinIBA 03/2022 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 09/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2021 - 04/2015
2	Epinephrine (Adrenaline)FDA LinkGeneric 10/2021 - 12/2012
2	Fibroblast Growth Factor-23IBA 01/2021 - 10/2016
2	CollagenIBA 01/2021 - 12/2018
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 09/2002
2	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2015
2	ApolipoproteinsIBA 01/2020 - 01/2015
2	Sirtuin 1IBA 12/2019 - 11/2018
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 01/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2019
2	LipidsIBA 01/2019 - 01/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 05/2017
2	Atrial Natriuretic Factor (ANF)IBA 12/2018 - 01/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2018 - 01/2015
2	PeriostinIBA 05/2018 - 05/2017
2	olmesartanIBA 05/2018 - 08/2014
2	Cyclin D1IBA 05/2018 - 05/2017
2	Glycogen Synthase KinasesIBA 05/2018 - 05/2017
2	P-SelectinIBA 01/2018 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 12/2016 - 01/2014
2	Transcription Factor CHOPIBA 08/2015 - 07/2010
2	Sirolimus (Rapamycin)FDA Link 06/2015 - 04/2003
2	Complementary DNA (cDNA)IBA 05/2015 - 01/2014
2	Glycoproteins (Glycoprotein)IBA 01/2015 - 11/2013
2	Platelet Membrane Glycoprotein IIbIBA 01/2015 - 11/2013
2	Histamine (Histamine Dihydrochloride)FDA Link 10/2014 - 05/2013

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2002
11	Microbubbles 01/2021 - 08/2011
6	Immunotherapy 01/2022 - 01/2019
5	Drug Therapy (Chemotherapy) 12/2021 - 01/2012
3	Aftercare (After-Treatment) 12/2016 - 11/2015
2	Adjuvant Chemotherapy 01/2022 - 01/2020
2	Sutures (Suture) 01/2021 - 01/2020
2	Length of Stay 08/2020 - 01/2020
2	Ultrasonic Therapy 01/2020 - 10/2018